Philips Gains FDA Clearance for AI Ultrasound Upgrade
AMSTERDAM, Netherlands, June 2, 2026 Royal Philips has received U.S. FDA 510(k) clearance and CE Mark approval for Elevate...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
AMSTERDAM, Netherlands, June 2, 2026 Royal Philips has received U.S. FDA 510(k) clearance and CE Mark approval for Elevate...
FREMONT, California, USA, June 2, 2026 Alamar Biosciences has unveiled its NULISAâ„¢ Dried Blood Spot (DBS) Extraction Kit, a...
HEIDELBERG, Germany, June 2, 2026 Hummingbird Diagnostics announced new research findings that provide important biological evidence supporting its liquid...
CHICAGO, Illinois, May 31, 2026 Johnson & Johnson has reported pivotal results from the Phase 1b/2 OrigAMI-4 study, demonstrating...
MENLO PARK, California, May 31, 2026 GRAIL, Inc. has unveiled compelling new results from its registrational PATHFINDER 2 study,...
VENLO, Netherlands & GERMANTOWN, Md., May 28, 2026 QIAGEN announced the availability of two custom-designed research-use-only (RUO) QIAcuity digital...
AUSTIN, Texas, May 26, 2026 TOBY, Inc., a biotechnology company focused on non-invasive disease detection technologies, has announced that...
ABBOTT PARK, Ill., May 27, 2026 Abbott has announced that the updated American Cancer Society (ACS) colorectal cancer screening...
SALT LAKE CITY, May 26, 2026 Myriad Genetics announced the launch of Prolaris® + AI, the first prostate cancer...
NASHIK, India, May 21, 2026 Datar Cancer Genetics (DCG) has achieved a major milestone in precision oncology after receiving...
